SCHEMBL6523401

SCHEMBL6523401

CCCCCCCCCCCCCCCCSCC(Nc1cc(C)c[nH]1)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GMNN O75496 1/20 0.36
TP53 P04637 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
CYP2C9 P11712 1/20 0.36
BLM P54132 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ICMT O60725 1/20 0.35
PLK1 P53350 3/20 0.34
CES2 O00748 1/20 0.33
NOD1 Q9Y239 1/20 0.33
SLC6A5 Q9Y345 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
PLA2G4B P0C869 2/20 0.32
GPR84 Q9NQS5 1/20 0.32
KDM6B O15054 1/20 0.32
KDM4A O75164 1/20 0.32
KDM4D Q6B0I6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13760291 0.85 ALDH1A1 (0.35) ALDH1A1GAA
SCHEMBL6526435 0.80 ICMT (0.38) GMNNTP53POLBMAPTTHRB
SCHEMBL6526406 0.78 KDM6B (0.40) GMNNTP53POLBMAPTTHRB
SCHEMBL6524718 0.76 ICMT (0.37) GMNNTP53POLBMAPTTHRB
SCHEMBL6522607 0.74 KDM4E (0.46) TP53MAPTCYP2C9ALDH1A1GAA
SCHEMBL12793162 0.74 FDPS (0.38) GMNNTP53POLBMAPTTHRB
SCHEMBL6521996 0.73 KDM4E (0.41) GMNNTP53POLBMAPTTHRB
SCHEMBL6520453 0.73 GMNN (0.40) GMNNTP53POLBMAPTTHRB
SCHEMBL6522561 0.71 LMNA (0.36) GMNNTP53POLBMAPTTHRB
SCHEMBL6524114 0.71 RAB9A (0.41) TP53MAPTHSD17B10ICMTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2011-03-03 US disclosed
WO-2009102997-A2 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE SIGNUM BIOSCIENCES, INC. (US) 2009-08-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053901-A1 ACETYL MIMIC COMPOUNDS FOR THE INHIBITION OF ISOPRENYL-S-CYSTEINYL METHYLTRANSFERASE MPO, CYSLTR1, HNMT GMNN 4376/4885TP53 3810/4885POLB 3041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.